chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Spinal decompression, Spinal fusion surgery, Staphylococcal infection
Clinical narrative: Received 3 dose vaccine on 5/3/22. Within first 24 hours experienced some discomfort and pain in back and neck. Some nausea an upset stomach. By 5/6/22 I went to ER. Over the next 11 days the pain became excruciating and paralysis started to set in on my extremities. In total I made 6-7 attempts to get help from multiple ERs, Urgent car, Orthopedic Care before finally being admitted to ER on 5/17/22. Diagnosis, many Epidural Abscess of cervical thoracic and  lumbar spine. Sepsis. Septic shock. MSSA. Spinal Cord Compression. DDD. Osteomyelitis. And others problems . Was rushed to emergency surgery had multiple disc removed. Cages pins screws placed. Spinal decompression. ICU 2 weeks. Extended Hospital stay and rehabilitation. Recurrent condition and symptoms led to more stays. Life long injuries. Morbidities Mortalities
Age: 20.0
Sex: M
Vaccine: YF
Symptoms: Dizziness, Dyspnoea, Hyperhidrosis, Injection site pain, Malaise
Clinical narrative: PATIENT RECEIVED VACCINE AND BEGAN FEELING ILL AS HE LEFT THE STORE. STATES HE BEGAN FEELING LIKE HE WAS GONNA FAINT, STARTED SWEATING, AND BECAME DIFFICULT TO BREATHE. ALSO STATES HE HAD TINGLING IN ARMS AND SORENESS AT INJECTION SITE. PATIENT SAT DOWN BUT HAD TO LAY DOWN AND BEGAN FEELING BETTER. EMS WAS CALLED TO STORE AND THEY TOOK OVER SITUATION.
Age: 20.0
Sex: M
Vaccine: YF
Symptoms: Paraesthesia
Clinical narrative: PATIENT RECEIVED VACCINE AND BEGAN FEELING ILL AS HE LEFT THE STORE. STATES HE BEGAN FEELING LIKE HE WAS GONNA FAINT, STARTED SWEATING, AND BECAME DIFFICULT TO BREATHE. ALSO STATES HE HAD TINGLING IN ARMS AND SORENESS AT INJECTION SITE. PATIENT SAT DOWN BUT HAD TO LAY DOWN AND BEGAN FEELING BETTER. EMS WAS CALLED TO STORE AND THEY TOOK OVER SITUATION.
Age: 18.0
Sex: F
Vaccine: UNK
Symptoms: Chest discomfort, Dyspnoea, Hypoxia, Swelling face, Urticaria
Clinical narrative: Patient was short of breath with chest tightness, urticaria, and facial swelling and hypoxic to 77% on room air with.  He was given epinephrine (epi-pen), benadryl, steroids and admitted to the hospital for observation.
Age: 68.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site pain, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Patient felt pain in her arm during vaccination and is still feeling pain in arm and to the side, with some stiffness to arm. She said this has happened to her before when she got vaccinated. Advised patient to keep arm mobile, she can take Tylenol and apply ice in 20 minute cycles. if pain becomes unbearable, advised her to go to urgent care.
Age: 63.0
Sex: F
Vaccine: HEPAB
Symptoms: Dysphagia, Lip swelling, Rash, Tongue pruritus
Clinical narrative: This patient received her 2nd Twinrix vaccine on 6/5 and she went to the ER during that night for swollen lips, itchy tongue, and difficulty swallowing. She received rx's for prednisone and famotidine today and will be taking diphenhydramine OTC. According to the patient, the ER was not sure of the cause of the reaction (she has been battling a rash with unknown cause for several weeks and they think it is related to that).
Age: 25.0
Sex: F
Vaccine: HPV9
Symptoms: Blood test, Bone densitometry, Disturbance in attention, Feeling abnormal, General physical health deterioration
Clinical narrative: STARTED OUT WITH IRREGULAR PERIODS THEN MOOD SWINGS, SLEEP ISSUES, HOT FLASHES, NIGHT SWEATS, CONCENTRATION ISSUES, SEX ISSUES...ESSENTIALLY EVERY SINGLE SYMPTOM OF MENOPAUSE UNDER THE SUN I HAVE HAD. IT'S TERRIBLE!   I HAD 3-SHOTS IN 2013 (4/26/2013, 6/8/2013, 10/15/2013) AND WITHIN MONTHS --- MY ALWAYS NORMAL PERIOD --- TURNED INTO AN IRREGULAR ONE.   HAD SOME TESTING DONE OVER THE YEARS AND NOTHING CAME UP AT FIRST. WASN'T UNTIL MY HORMONE LEVELS COMPLETELY DROPPED IN 2021 THAT ANYTHING WAS ABLE TO BE DIAGNOSED.   SO I SUFFERED FROM 2014 THROUGH TODAY! THIS VACCINE RUINED MY LIFE. I'M LIKE A BLASTED GUINEA PIG NOW TO THE "WOMENS CARE" PROFESSIONALS. THEY HAVE NO IDEA HOW TO TREAT ME.   I FEEL TERRIBLE ALL THE TIME! AND MY HEALTH CONTINUES TO GO DOWN HILL. MY BODY HAS SHRIVELED UP. I'LL BE LUCKY TO MAKE IT TO 50 OR 60.
Age: 25.0
Sex: F
Vaccine: HPV9
Symptoms: Hormone level abnormal, Hot flush, Impaired quality of life, Laboratory test normal, Menopausal symptoms
Clinical narrative: STARTED OUT WITH IRREGULAR PERIODS THEN MOOD SWINGS, SLEEP ISSUES, HOT FLASHES, NIGHT SWEATS, CONCENTRATION ISSUES, SEX ISSUES...ESSENTIALLY EVERY SINGLE SYMPTOM OF MENOPAUSE UNDER THE SUN I HAVE HAD. IT'S TERRIBLE!   I HAD 3-SHOTS IN 2013 (4/26/2013, 6/8/2013, 10/15/2013) AND WITHIN MONTHS --- MY ALWAYS NORMAL PERIOD --- TURNED INTO AN IRREGULAR ONE.   HAD SOME TESTING DONE OVER THE YEARS AND NOTHING CAME UP AT FIRST. WASN'T UNTIL MY HORMONE LEVELS COMPLETELY DROPPED IN 2021 THAT ANYTHING WAS ABLE TO BE DIAGNOSED.   SO I SUFFERED FROM 2014 THROUGH TODAY! THIS VACCINE RUINED MY LIFE. I'M LIKE A BLASTED GUINEA PIG NOW TO THE "WOMENS CARE" PROFESSIONALS. THEY HAVE NO IDEA HOW TO TREAT ME.   I FEEL TERRIBLE ALL THE TIME! AND MY HEALTH CONTINUES TO GO DOWN HILL. MY BODY HAS SHRIVELED UP. I'LL BE LUCKY TO MAKE IT TO 50 OR 60.
Age: 25.0
Sex: F
Vaccine: HPV9
Symptoms: Menstruation irregular, Mood swings, Night sweats, Sexual dysfunction, Sleep disorder
Clinical narrative: STARTED OUT WITH IRREGULAR PERIODS THEN MOOD SWINGS, SLEEP ISSUES, HOT FLASHES, NIGHT SWEATS, CONCENTRATION ISSUES, SEX ISSUES...ESSENTIALLY EVERY SINGLE SYMPTOM OF MENOPAUSE UNDER THE SUN I HAVE HAD. IT'S TERRIBLE!   I HAD 3-SHOTS IN 2013 (4/26/2013, 6/8/2013, 10/15/2013) AND WITHIN MONTHS --- MY ALWAYS NORMAL PERIOD --- TURNED INTO AN IRREGULAR ONE.   HAD SOME TESTING DONE OVER THE YEARS AND NOTHING CAME UP AT FIRST. WASN'T UNTIL MY HORMONE LEVELS COMPLETELY DROPPED IN 2021 THAT ANYTHING WAS ABLE TO BE DIAGNOSED.   SO I SUFFERED FROM 2014 THROUGH TODAY! THIS VACCINE RUINED MY LIFE. I'M LIKE A BLASTED GUINEA PIG NOW TO THE "WOMENS CARE" PROFESSIONALS. THEY HAVE NO IDEA HOW TO TREAT ME.   I FEEL TERRIBLE ALL THE TIME! AND MY HEALTH CONTINUES TO GO DOWN HILL. MY BODY HAS SHRIVELED UP. I'LL BE LUCKY TO MAKE IT TO 50 OR 60.
Age: 25.0
Sex: F
Vaccine: HPV9
Symptoms: Ultrasound scan vagina
Clinical narrative: STARTED OUT WITH IRREGULAR PERIODS THEN MOOD SWINGS, SLEEP ISSUES, HOT FLASHES, NIGHT SWEATS, CONCENTRATION ISSUES, SEX ISSUES...ESSENTIALLY EVERY SINGLE SYMPTOM OF MENOPAUSE UNDER THE SUN I HAVE HAD. IT'S TERRIBLE!   I HAD 3-SHOTS IN 2013 (4/26/2013, 6/8/2013, 10/15/2013) AND WITHIN MONTHS --- MY ALWAYS NORMAL PERIOD --- TURNED INTO AN IRREGULAR ONE.   HAD SOME TESTING DONE OVER THE YEARS AND NOTHING CAME UP AT FIRST. WASN'T UNTIL MY HORMONE LEVELS COMPLETELY DROPPED IN 2021 THAT ANYTHING WAS ABLE TO BE DIAGNOSED.   SO I SUFFERED FROM 2014 THROUGH TODAY! THIS VACCINE RUINED MY LIFE. I'M LIKE A BLASTED GUINEA PIG NOW TO THE "WOMENS CARE" PROFESSIONALS. THEY HAVE NO IDEA HOW TO TREAT ME.   I FEEL TERRIBLE ALL THE TIME! AND MY HEALTH CONTINUES TO GO DOWN HILL. MY BODY HAS SHRIVELED UP. I'LL BE LUCKY TO MAKE IT TO 50 OR 60.
Age: 86.0
Sex: F
Vaccine: PNC20
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: 1 month later and patient is complaining of a sore arm in the joint
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Injected limb mobility decreased, Palpitations
Clinical narrative: Increase heart palpitations that forced me to the ER on two occasions.  Dizziness, short of breath, lack of movement in left arm.
Age: 41.0
Sex: F
Vaccine: PNC20
Symptoms: Fatigue, Injection site erythema, Injection site swelling, Injection site warmth, Lymph node pain
Clinical narrative: Lymph node on my collar bone on the left side was very swollen and now the area where I got the shot is very red and hot and swollen and my arm and several lymph nodes on the left side are swollen and painful.  feeling very exhausted, nauseated, fever.
Age: 41.0
Sex: F
Vaccine: PNC20
Symptoms: Lymphadenopathy, Nausea, Peripheral swelling, Pyrexia
Clinical narrative: Lymph node on my collar bone on the left side was very swollen and now the area where I got the shot is very red and hot and swollen and my arm and several lymph nodes on the left side are swollen and painful.  feeling very exhausted, nauseated, fever.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiomyopathy, Electrocardiogram abnormal, Myocarditis
Clinical narrative: 5/4/23 myocarditis, cardiomyopathy
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site bruising
Clinical narrative: bruise at injection site still not resolved after 2 weeks
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Cough, Dyspnoea, Echocardiogram normal, Pneumonia viral
Clinical narrative: Dr. received Moderna Bivalent booster on May 6, 2023. Approximately 2 weeks later, he began experiencing shortness of breath which progressively got worse. On 06/03/23, he presented at the locsl Emergency Department with chief complaints of shortness of breath and dry cough. On 06/04/23, he presented at the the local Emergency Department with same complaints. He was diagnosed with Viral Pneumonitis. On 06/05/23, he presented at the Emergency Department with progressively worsening symptoms. Pulse Ox was 82% at room air. An Echocardiogram was administed which yielded normal results. He is currently admitted to local Hospital being treated with antibiotics for diagnosis of Sepsis with acute hypoxic respiratory failure.
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Sepsis
Clinical narrative: Dr. received Moderna Bivalent booster on May 6, 2023. Approximately 2 weeks later, he began experiencing shortness of breath which progressively got worse. On 06/03/23, he presented at the locsl Emergency Department with chief complaints of shortness of breath and dry cough. On 06/04/23, he presented at the the local Emergency Department with same complaints. He was diagnosed with Viral Pneumonitis. On 06/05/23, he presented at the Emergency Department with progressively worsening symptoms. Pulse Ox was 82% at room air. An Echocardiogram was administed which yielded normal results. He is currently admitted to local Hospital being treated with antibiotics for diagnosis of Sepsis with acute hypoxic respiratory failure.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site irritation, Injection site swelling, Pain in extremity, Palpitations
Clinical narrative: EXTREME IRRITATION AND SWELLING AT INJECTION SITE, HEART PALPITATIONS, AND CONSTANT PAIN IN RIGHT LEG
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal discomfort, Chills, Headache
Clinical narrative: pt developed chill, sick on her stomach and headache after receiving the vaccine and she still has it now
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was administered vaccine on 12/20/22that expired  12/2/22.  No adverse events reported from the vaccine or known issues.  The event is being reported due to the patient receiving a vaccine that was expired
Age: 53.0
Sex: F
Vaccine: PNC20, PNC20
Symptoms: Pain in extremity, Paraesthesia, Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: Patient received the vaccine on 5/31/2023. She came to the pharmacy on 6/5/2023 with swollen arm. She said it was painful, itchy and tingling. She was prescribed hydroxyzine 10 mg at bedtime on 6/5/2023. She then developed a fever of 101 degrees  on 6/5/2023. She was prescribed doxycycline mono 100 mg capsules twice a day for 7 days.
Age: 53.0
Sex: F
Vaccine: PNC20, PNC20
Symptoms: Erythema, Headache, Pain in extremity, Pyrexia
Clinical narrative: Patient received the vaccine on 5/31/2023. She came to the pharmacy on 6/5/2023 with swollen arm. She said it was painful, itchy and tingling. She was prescribed hydroxyzine 10 mg at bedtime on 6/5/2023. She then developed a fever of 101 degrees  on 6/5/2023. She was prescribed doxycycline mono 100 mg capsules twice a day for 7 days.
Age: 18.0
Sex: F
Vaccine: HPV9, MENB
Symptoms: Loss of consciousness, Magnetic resonance imaging head
Clinical narrative: Pt was given vaccine in Room. Stated she was alright left Room went to Reception. This nurse saw her in Reception asked if she was alright, she said she could use a juice. When this Nurse Returned with juice pt. had loss consciousness. Called code, called MD. MD and Nurse lifted pt to ground.
Age: 65.0
Sex: F
Vaccine: HEPA, PPV
Symptoms: Abdominal discomfort, Condition aggravated, Discomfort, Drooling, Dyspnoea
Clinical narrative: Written by husband, observer of episode in question. Times are approximate. Patient reported discomfort starting soon after injection that worsened as the day proceeded. By midafternoon she was feeling quite poorly in general and began to have gastric upset. She lay down by 1600 and as evening progressed her condition worsened. Stomach upset and overall discomfort worsened into evening. At about 2000 she went to the commode where she sat for 15 or more minutes. After this approximate length of time observer noticed her head hanging down and drool emitting from mouth. She was cleaned up and assisted to bed, walking being very difficult and mental function definitely impaired. She was still communicative but was showing signs of an impending seizure.   After 10 or so minutes she was dressed as observer intended to take her via personal vehicle to local emergency room. Within minutes of deciding of course of action, it became apparent that she was no longer capable of walking or assisting in movement to car. She lay down in bed and remained for another 30 minutes est.   During this period communication was attempted to assess the seriousness of the situation. She had experienced a small number of seizures in the recent past which had been quite mild and short in duration. As this was hoped for and possible, she was observed in anticipation of the event passing on its own. After possibly an hour it was determined that this was going to be a more serious event and an ambulance was called. It took some time to arrive, by which time she was apparently under the effects of a full seizure.   She was intubated by medics as she was experiencing breathing difficulties. I believe that with much more delay in calling for ambulance she could have died due to failure of breathing.
Age: 65.0
Sex: F
Vaccine: HEPA, PPV
Symptoms: Endotracheal intubation, Feeling abnormal, Gait disturbance, Gait inability, General physical health deterioration
Clinical narrative: Written by husband, observer of episode in question. Times are approximate. Patient reported discomfort starting soon after injection that worsened as the day proceeded. By midafternoon she was feeling quite poorly in general and began to have gastric upset. She lay down by 1600 and as evening progressed her condition worsened. Stomach upset and overall discomfort worsened into evening. At about 2000 she went to the commode where she sat for 15 or more minutes. After this approximate length of time observer noticed her head hanging down and drool emitting from mouth. She was cleaned up and assisted to bed, walking being very difficult and mental function definitely impaired. She was still communicative but was showing signs of an impending seizure.   After 10 or so minutes she was dressed as observer intended to take her via personal vehicle to local emergency room. Within minutes of deciding of course of action, it became apparent that she was no longer capable of walking or assisting in movement to car. She lay down in bed and remained for another 30 minutes est.   During this period communication was attempted to assess the seriousness of the situation. She had experienced a small number of seizures in the recent past which had been quite mild and short in duration. As this was hoped for and possible, she was observed in anticipation of the event passing on its own. After possibly an hour it was determined that this was going to be a more serious event and an ambulance was called. It took some time to arrive, by which time she was apparently under the effects of a full seizure.   She was intubated by medics as she was experiencing breathing difficulties. I believe that with much more delay in calling for ambulance she could have died due to failure of breathing.
Age: 65.0
Sex: F
Vaccine: HEPA, PPV
Symptoms: Mental impairment, Mobility decreased, Posture abnormal, Seizure, Seizure like phenomena
Clinical narrative: Written by husband, observer of episode in question. Times are approximate. Patient reported discomfort starting soon after injection that worsened as the day proceeded. By midafternoon she was feeling quite poorly in general and began to have gastric upset. She lay down by 1600 and as evening progressed her condition worsened. Stomach upset and overall discomfort worsened into evening. At about 2000 she went to the commode where she sat for 15 or more minutes. After this approximate length of time observer noticed her head hanging down and drool emitting from mouth. She was cleaned up and assisted to bed, walking being very difficult and mental function definitely impaired. She was still communicative but was showing signs of an impending seizure.   After 10 or so minutes she was dressed as observer intended to take her via personal vehicle to local emergency room. Within minutes of deciding of course of action, it became apparent that she was no longer capable of walking or assisting in movement to car. She lay down in bed and remained for another 30 minutes est.   During this period communication was attempted to assess the seriousness of the situation. She had experienced a small number of seizures in the recent past which had been quite mild and short in duration. As this was hoped for and possible, she was observed in anticipation of the event passing on its own. After possibly an hour it was determined that this was going to be a more serious event and an ambulance was called. It took some time to arrive, by which time she was apparently under the effects of a full seizure.   She was intubated by medics as she was experiencing breathing difficulties. I believe that with much more delay in calling for ambulance she could have died due to failure of breathing.
Sex: U
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: No adverse event; On 10 May 2023, 27 patients received 0.25ml of the Moderna bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (On 10 May 2023, 27 patients received 0.25ml of the Moderna bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 067H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-May-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 10-May-2023, the patient experienced UNDERDOSE (On 10 May 2023, 27 patients received 0.25ml of the Moderna bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (On 10 May 2023, 27 patients received 0.25ml of the Moderna bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (On 10 May 2023, 27 patients received 0.25ml of the Moderna bivalent vaccine).    This case was for 26th patient out of 27 patients. Patients was an over the age of 65 years. The vaccination site was reported as deltoid. Concomitant medications were not reported.  No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-723833 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-723833:Master case
Age: 1.08
Sex: U
Vaccine: MMR, VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse events were reported; Products were administered post TE; This spontaneous report was received from a registered nurse referring to a 13-month-old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.     On 10-MAR-2023, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) injection (lot # W001518, expiration date: 13-JAN-2024 or lot # W007040, expiration date: 29-FEB-2024; no exact lot# and expiration date was provided) and varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot # W008711, expiration date: 14-MAR-2024 or lot # W017552, expiration date: 01-JUN-2024; no exact lot# and expiration date was provided) (both strengths, doses, routes of administration and anatomical locations were not reported), both for prophylaxis (product storage error). No additional adverse event (AE) was reported (no adverse event).  This case was received from the same reporter with another 17 cases: 2305USA007704, 2305USA009080,2305USA009081,2305USA009082,2305USA009083, 2305USA009084, 2305USA009085, 2305USA009086, 2305USA009087, 2305USA009088, 2305USA009089, 2305USA009090, 2305USA009091, 2305USA009092, 2305USA009093, 2305USA009094, 2305USA009095.
Age: 1.08
Sex: U
Vaccine: MMR, VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse events were reported; Products were administered post TE; This spontaneous report was received from a registered nurse referring to a 13-month-old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.     On 10-MAR-2023, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) injection (lot # W001518, expiration date: 13-JAN-2024 or lot # W007040, expiration date: 29-FEB-2024; no exact lot# and expiration date was provided) and varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot # W008711, expiration date: 14-MAR-2024 or lot # W017552, expiration date: 01-JUN-2024; no exact lot# and expiration date was provided) (both strengths, doses, routes of administration and anatomical locations were not reported), both for prophylaxis (product storage error). No additional adverse event (AE) was reported (no adverse event).  This case was received from the same reporter with another 17 cases: 2305USA007704, 2305USA009079,2305USA009081,2305USA009082,2305USA009083, 2305USA009084, 2305USA009085, 2305USA009086, 2305USA009087, 2305USA009088, 2305USA009089, 2305USA009090, 2305USA009091, 2305USA009092, 2305USA009093, 2305USA009094, 2305USA009095.
Age: 1.0
Sex: U
Vaccine: MMR, VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse events were reported; Products were administered post TE; This spontaneous report was received from a registered nurse referring to a 12-month-old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.     On 24-MAR-2023, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) injection (lot # W001518, expiration date: 13-JAN-2024 or lot # W007040, expiration date: 29-FEB-2024; no exact lot# and expiration date was provided) and varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot # W008711, expiration date: 14-MAR-2024 or lot # W017552, expiration date: 01-JUN-2024; no exact lot# and expiration date was provided) (both strengths, doses, routes of administration and anatomical locations were not reported), both for prophylaxis (product storage error). No additional adverse event (AE) was reported (no adverse event).  This case was received from the same reporter with another 17 cases: 2305USA007704, 2305USA009079,2305USA009080,2305USA009081,2305USA009082, 2305USA009083, 2305USA009085, 2305USA009086, 2305USA009087, 2305USA009088, 2305USA009089, 2305USA009090, 2305USA009091, 2305USA009092, 2305USA009093, 2305USA009094, 2305USA009095.
Age: 33.0
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse events were reported; Products were administered post TE; This spontaneous report was received from a registered nurse referring to a 33-year-old patient of unknown gender. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.     On 20-APR-2023, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot # W008711, expiration date: 14-MAR-2024 or lot # W017552, expiration date: 01-JUN-2024; no exact lot# and expiration date was provided) (both strengths, doses, routes of administration and anatomical locations were not reported), both for prophylaxis (product storage error). No additional adverse event (AE) was reported (no adverse event).  This case was received from the same reporter with another 17 cases: 2305USA007704, 2305USA009079,2305USA009080,2305USA009081,2305USA009082, 2305USA009083, 2305USA009084, 2305USA009085, 2305USA009086, 2305USA009087, 2305USA009088, 2305USA009089, 2305USA009090, 2305USA009091, 2305USA009093, 2305USA009094, 2305USA009095.
Sex: U
Vaccine: HPV9
Symptoms: Extra dose administered, No adverse event
Clinical narrative: a patient received two doses of the GARDASIL 9 vaccine in the same day inadvertently; No additional AE; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported.   On an unknown date, the patient inadvertently received two doses of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection (product quantity: 1; strength, dose, route of administration, anatomical location, lot#, and expiration date were not reported) for prophylaxis in the same day (extra dose administered). No additional adverse event (AE) was reported (no adverse event).
Age: 0.17
Sex: U
Vaccine: HIBV
Symptoms: No adverse event, Overdose
Clinical narrative: No additional adverse events; 8 week old child inadvertently received 2 doses of PEDVAX HIB.; This spontaneous report was received from nurse practitioner concerning an 8-week-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 30-MAY-2023, the patient was inadvertently vaccinated with 2 doses of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, 1 milliliter (2 0.5ml vials were drawn up), lot #W032685, expiration date: 08-MAY-2025, administered intramuscularly as prophylaxis (strength was not provided) (Overdose). No additional adverse events were reported.
Age: 0.17
Sex: U
Vaccine: HIBV
Symptoms: Inappropriate schedule of product administration, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No additional adverse event; Inbound call from physician calling to report AE for PEDVAXHIB.  Caller states that she has a 6 month old patient who received a 3rd dose of PEDVAXHIB.  Patient received their 1st dose at 2 months and their 2nd dose at 4 months.  No symptomatic adver; month old patient who received a 3rd dose; This spontaneous report was received from a physician concerning a 6-month-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date in 2023, the patient was vaccinated with the first dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, administered as prophylaxis (strength, lot #, expiry date, and route of administration were not provided) at 2 months old. The patient received a second dose when they was 4 months old.   On 30-MAY-2023, when the patient was 6 months old, the patient received a third dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5 milliliter lot#W015928, expiration date: 24-FEB-2025 (Inappropriate schedule of product administration) (Product administered to patient of inappropriate age). No symptomatic adverse events were reported.
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse event; HCP calling to report that PROQUAD was administered after undergoing a TE.; This spontaneous report was received from a nurse referring to a unknown age and gender patient. No information regarding the patient's medical history, concurrent conditions, previous drug reactions or allergies and concomitant medications was provided.  On an unknown date in February 2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA) (PROQUAD) subcutaneous injection, 0.5 milliliter, lot #W019631, (who had been verified to be a valid number; expiration date: 19-DEC-2023, and upon internal validation established as the same date) administered for prophylaxis (strength and route of administration was not provided). The vaccine was given after it experienced a temperature excursion of 13.5 F (Fahrenheit) with a time frame of 3 hours, 5 minutes, 0 seconds. There was no information about previous temperature excursion (improper storage of product in use). No adverse event was reported.
Age: 0.5
Sex: U
Vaccine: RV5
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Confirmed with caller no other AE occurred; a 26 week 5 day old patient received their first dose of ROTATEQ on 5/31/2023.; This spontaneous report was received from a medical assistant and referred to a 26-week-and-5-day-old patient of unspecified gender. The patient's pertinent medical history, current conditons, previous drug reactions or allergies, and concomitant medications were not reported.  On 31-MAY-2023, the 26 week and 5 days old patient received the first dose (also reported as 1 dose) of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) administered orally as prophylaxis (strength, dose, and vaccination scheme frequency were not reported; lot number 1879875 that was verified to be valid with an expiration date reported and established as 19-NOV-2023) (product administered to patient of inappropriate age). The reporter confirmed that no other adverse event (AE) occurred.    This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2305USA010555:
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No further AE details; PROQUAD was improperly stored and administered to a patient; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender.  The patient's medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported.  On 06-APR-2023, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live, rHA (recombinant human albumin) (PROQUAD) subcutaneous injection, 0.5 milliliter, once (lot number W016357 has been verified to be valid for measles, mumps, rubella and varicella (oka-merck) virus vaccine live, rHA [PROQUAD], expiration date reported and confirmed as 16-NOV-2023) (route of administration and anatomical location were not provided) as prophylaxis. The vaccine administered was stored at a temperature of 19.6 degree Fahrenheit (F), during a time frame of 7 Hours 20 Minutes 0 Seconds, and did not suffered previous temperature excursion (Product storage error). No further adverse event (AE) details nor product quality complaints (PQC) were reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2306USA001063:
Age: 59.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Immediate post-injection reaction, Incomplete course of vaccination, Urticaria
Clinical narrative: Shingrix: possible only 1 dose received; shingrix: developed Hives immediately; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of hives in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number h49ma, expiry date 29-SEP-2023) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 27-SEP-2022, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On 27-SEP-2022, immediately after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced hives (Verbatim: shingrix: developed Hives immediately). On an unknown date, the patient experienced incomplete course of vaccination (Verbatim: Shingrix: possible only 1 dose received). The outcome of the hives was not resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the hives to be related to Shingrix.     It was unknown if the company considered the hives to be related to Shingrix.   Additional Information: GSK Receipt Date: 05-JUN-2023 The pharmacist reported that a patient received 1st dose of Shingrix and developed hives immediately.  The patient said that she had it ever since then non- stop.  The healthcare professional was not sure if patient received the 2nd dose or not. The reporter did not consent to follow-up. There was a possibility that the patient recevied only one dose of Shingrix. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Age: 53.0
Sex: F
Vaccine: PNC20, PNC20
Symptoms: Pain in extremity, Paraesthesia, Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: RED ARM, PAINFUL, FEVER, HEADACHE , LOOKS HORRIBLE, NEVER SEEN SOMETHING LIKE THIS.
Age: 53.0
Sex: F
Vaccine: PNC20, PNC20
Symptoms: Erythema, Headache, Pain in extremity, Pyrexia
Clinical narrative: RED ARM, PAINFUL, FEVER, HEADACHE , LOOKS HORRIBLE, NEVER SEEN SOMETHING LIKE THIS.
Age: 25.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pruritus, Injection site urticaria, Injection site warmth
Clinical narrative: Large hive at injection site. Very itchy and warm. Hive is the about 3 inches by 1 inch
Age: 74.0
Sex: F
Vaccine: FLU4
Symptoms: Expired product administered, Product administration error
Clinical narrative: Vaccine administered on 6/2/23. Vaccine expired 5/31/23. Awaiting patient to return call to inform her of error and if any adverse effects. Seqirus was contacted for information for which I was told to revaccinate.MD was notified of error and told what manufacturer recommended.  MD responded that flu season has ended so revaccination was not needed. However patient could get revaccinated again if she wished
Sex: U
Vaccine: HPV9
Symptoms: Expired product administered, No adverse event
Clinical narrative: No Adverse Event; Caller reported expired dose of GARDASIL 9 was administered.   No other information provided.  No additional AEs or PQC reported.; This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.   On 02-JUN-2023, the patient was vaccinated with expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # U007667, expiration date: 23-MAY-2023, 0.5 milliliter, intramuscular (anatomical location was not reported) for prophylaxis (expired product administered). No additional adverse event reported (no adverse event).
Sex: U
Vaccine: VARZOS
Symptoms: Abnormal sensation in eye, Herpes ophthalmic
Clinical narrative: I developed a full blown Herpes Infection in that eye; after the vaccine my right eye started feeling weird; This serious case was reported by a consumer and described the occurrence of herpes ophthalmic in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included herpes ophthalmic (the patient had a prior medical history of a herpes right eye Infection which flared up approximately every 6 to 9 months when patient became either fatigue or extremely stressed), fatigue and stress. Previously administered products included Valtrex (the patient was taking Valtrex 500 to 1000 mg whenever had an infection). Additional patient notes included had no flare ups for almost a year and decided to get first Shingrix vaccine.   On 19-JAN-2023, the patient received the 1st dose of Shingrix. In JAN-2023, 1 week after receiving Shingrix, the patient experienced herpes ophthalmic (Verbatim: I developed a full blown Herpes Infection in that eye) (serious criteria GSK medically significant) and abnormal sensation in eye (Verbatim: after the vaccine my right eye started feeling weird). The outcome of the herpes ophthalmic and abnormal sensation in eye were not reported.   It was unknown if the reporter considered the herpes ophthalmic and abnormal sensation in eye to be related to Shingrix.     It was unknown if the company considered the herpes ophthalmic and abnormal sensation in eye to be related to Shingrix.   Additional Information: GSK Receipt Date: 31-MAY-2023 The patient self reported this case. About a week after the vaccine the patient's right eye started feeling weird and developed a full blown Herpes Infection in that eye. The patient was wondering if they should take a chance of getting the second shot. The reporter asked if Valtrex could be administered before the second shot or immediately after the second shot. Even the doctor could not answer this question.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; HCP gave an expired Moderna bivalent vaccine today 02-Jun-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP gave an expired Moderna bivalent vaccine today 02-Jun-2023) and NO ADVERSE EVENT (No adverse event) in a 41-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 015H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Jun-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 02-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP gave an expired Moderna bivalent vaccine today 02-Jun-2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP gave an expired Moderna bivalent vaccine today 02-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (HCP gave an expired Moderna bivalent vaccine today 02-Jun-2023).    Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant medication was reported.  The vial did not undergo any temperature excursions. No treatment information was reported.   This case was linked to MOD-2023-727539 (Patient Link).
Age: 68.0
Sex: F
Vaccine: PNC20
Symptoms: Cough, Injection site bruising, Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: cough-Medium
Age: 35.0
Sex: M
Vaccine: TDAP
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Pain
Clinical narrative: Site: Pain at Injection Site-Medium, Additional Details: Patient states pain radiates from injection site down to elbow since 2 days following vaccine. Patient has tried ice packs and tylenol and only receive temporary relief.
Age: 14.0
Sex: M
Vaccine: MNQ
Symptoms: Asthenia, Chills, Dizziness, Flushing, Hyperhidrosis
Clinical narrative: Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Systemic: Weakness-Mild
Age: 14.0
Sex: M
Vaccine: MNQ
Symptoms: Hypotension, Nausea
Clinical narrative: Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Systemic: Weakness-Mild
Age: 90.0
Sex: F
Vaccine: TDAP
Symptoms: Expired product administered, No adverse event
Clinical narrative: No reaction, was given an expired vaccine. No treatment required
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA
Sex: M
Vaccine: HPV9, HPV9, HPV9, HPV9, HPV9
Symptoms: Medication error, No adverse event, Product storage error
Clinical narrative: no adverse event; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to male patient.   The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On 14-FEB-2023, the patient was vaccinated with one of the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions for total time: 25 minutes (product storage error). There were 3 excursions reported on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 01-JAN-2023 for 12 minutes. Excursions were not noted until after the fact due to employee error of cleaning data logger more than once a day. No additional adverse event (AE) details were reported (no adverse event).   The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This is one of several reports received from the same reporter.
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia, Symptom recurrence
Clinical narrative: HYPOXEMIA 10/18/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 0.75
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC15
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered, No adverse event, Product administration error
Clinical narrative: There has been no adverse event to occur.  Vaccine administration error of extra doses given due 2 months vaccinations not being documented which results in all doses being 4th dose administration not 3rd.
Age: 1.0
Sex: F
Vaccine: MMRV, PNC13
Symptoms: Abnormal behaviour, Culture urine, Cyanosis, Electroencephalogram, Fatigue
Clinical narrative: On 5/27/23, patient had a staring event followed by perioral cyanosis then fatigue. Taken to ED, observed and sent home. Mother of patient felt uncomfortable with how she was acting, called Pediatrics. Described event. Recommended to take to Medical Center ED. A second episode happened and patient felt warm to mother. Then in ED, 3rd episode happened, witnessed by medical staff and confirmed as a third seizure. Admitted for observation and testing.  On Day 2-3 of admission while still febrile, patient had urinalysis done which showed evidence of a urinary tract infection. Given antibiotics, improved and discharged home on day 4 (day 9 after immunization).
Age: 1.0
Sex: F
Vaccine: MMRV, PNC13
Symptoms: Laboratory test, Pyrexia, Seizure, Skin warm, Staring
Clinical narrative: On 5/27/23, patient had a staring event followed by perioral cyanosis then fatigue. Taken to ED, observed and sent home. Mother of patient felt uncomfortable with how she was acting, called Pediatrics. Described event. Recommended to take to Medical Center ED. A second episode happened and patient felt warm to mother. Then in ED, 3rd episode happened, witnessed by medical staff and confirmed as a third seizure. Admitted for observation and testing.  On Day 2-3 of admission while still febrile, patient had urinalysis done which showed evidence of a urinary tract infection. Given antibiotics, improved and discharged home on day 4 (day 9 after immunization).
Age: 1.0
Sex: F
Vaccine: MMRV, PNC13
Symptoms: Urinary tract infection, Urine analysis abnormal
Clinical narrative: On 5/27/23, patient had a staring event followed by perioral cyanosis then fatigue. Taken to ED, observed and sent home. Mother of patient felt uncomfortable with how she was acting, called Pediatrics. Described event. Recommended to take to Medical Center ED. A second episode happened and patient felt warm to mother. Then in ED, 3rd episode happened, witnessed by medical staff and confirmed as a third seizure. Admitted for observation and testing.  On Day 2-3 of admission while still febrile, patient had urinalysis done which showed evidence of a urinary tract infection. Given antibiotics, improved and discharged home on day 4 (day 9 after immunization).
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 84.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia
Clinical narrative: HYPOXEMIA
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension, Ischaemic stroke
Clinical narrative: ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY HYPOTENSION
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, COVID-19, Hypoaesthesia, Pain, Pyrexia
Clinical narrative: I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 on 09/30/2022. I had a fever, aches and loss sense of taste. The bottom of my feet felt numb at times. I contacted my doctor and got a prescription for Paxlovid. I had no complications taking the medication. As of today, I have no lingering symptoms from COVID-19.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 on 09/30/2022. I had a fever, aches and loss sense of taste. The bottom of my feet felt numb at times. I contacted my doctor and got a prescription for Paxlovid. I had no complications taking the medication. As of today, I have no lingering symptoms from COVID-19.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lacunar stroke
Clinical narrative: ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Thalamic stroke
Clinical narrative: ACUTE STROKE OF THALAMUS, UNSPECIFIED TYPE AND ARTERY